Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bleeding associated with thromboprophylaxis: a multifactorial issue.

Fred D Cushner1

  • 1Insall Scott Kelly Institute, Beth Israel Medical Center, New York, NY, USA.

Orthopedics
|February 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proceedings of The Knee Society 2025 Members Meeting.

The Journal of arthroplasty·2026
Same author

Obesity and Total Knee Arthroplasty Revisited: Minimal Impact on Loosening and Mechanical Failure in the Modern Era.

The Journal of arthroplasty·2026
Same author

Obesity Severity and Stiffness After Total Knee Arthroplasty Revisited: A Contemporary Analysis of Patients Requiring Manipulation Under Anesthesia.

The Journal of arthroplasty·2026
Same author

Aspirin prophylaxis is safe and effective for venous thromboembolism prophylaxis in low-risk patients undergoing aseptic revision total knee arthroplasty : evidence from a national cohort.

The bone & joint journal·2026
Same author

Effects of Perioperative Dronabinol Use in Total Knee Arthroplasty: A Double-blinded Randomized Controlled Trial.

Anesthesiology·2026
Same author

Recovery of Ambulation After Staged Bilateral Total Knee Arthroplasty Is Not Affected by Timing of Second Side Surgery: A Retrospective Analysis of Implanted Sensor Data.

The Journal of arthroplasty·2025
Same journal

Rising Incidence of Group A Streptococcal Musculoskeletal Infections in Pediatric Patients.

Orthopedics·2026
Same journal

Comparative Outcomes of Lower Extremity Fractures in Patients With Type 1 and Type 2 Diabetes: A Retrospective Database Analysis.

Orthopedics·2026
Same journal

Declining Overall Use of Cervical Disk Arthroplasty in Medicare Beneficiaries Despite Outpatient Migration, 2016 to 2022.

Orthopedics·2026
Same journal

Examining the Statistical Fragility of Randomized Trials on Operative Versus Nonoperative Treatment of Acromioclavicular Joint Separation Using the Reverse Continuous Fragility Index.

Orthopedics·2026
Same journal

Understanding One-year Mortality Rates and Comorbidity Burden in Older Adults Following Hip Fracture.

Orthopedics·2026
Same journal

Preoperative Copper-to-Zinc Ratio and Postoperative Delirium After Hip Fracture Surgery: A Propensity Score-matched Cohort Study.

Orthopedics·2026
See all related articles

Anticoagulant use in total joint arthroplasty reduces venous thromboembolism risk. While postoperative bleeding is a concern, clinical trial data show thromboprophylaxis remains a safe and effective strategy.

Area of Science:

  • Orthopedic Surgery
  • Pharmacology
  • Vascular Medicine

Background:

  • Postoperative bleeding is a concern with anticoagulants for thromboprophylaxis in total joint arthroplasty.
  • Bleeding risk is multifactorial, influenced by patient factors, anticoagulant protocols, and surgical techniques.

Purpose of the Study:

  • To evaluate the incidence of bleeding in clinical trials of anticoagulant thromboprophylaxis for total joint arthroplasty.
  • To assess the safety and efficacy of thromboprophylaxis in this patient population.

Main Methods:

  • Review and evaluation of clinical trial data on anticoagulant use.
  • Analysis of factors influencing postoperative bleeding, including preoperative risks, anticoagulant details, and surgical variables.

Related Experiment Videos

Main Results:

  • Reported bleeding rates associated with various anticoagulants are generally low.
  • Risks of venous thromboembolism are significantly high in the absence of prophylaxis.

Conclusions:

  • Thromboprophylaxis is a safe and effective strategy for reducing morbidity and mortality in patients undergoing total joint arthroplasty.
  • The benefits of thromboprophylaxis outweigh the risks of bleeding in most cases.